Integrated Quantitative Investments LLC purchased a new position in Phibro Animal Health Co. (NASDAQ:PAHC – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 48,941 shares of the company’s stock, valued at approximately $1,028,000. Integrated Quantitative Investments LLC owned 0.12% of Phibro Animal Health at the end of the most recent reporting period.
A number of other hedge funds have also modified their holdings of PAHC. Quantbot Technologies LP purchased a new position in shares of Phibro Animal Health in the third quarter valued at about $70,000. Meeder Asset Management Inc. purchased a new stake in shares of Phibro Animal Health during the 4th quarter worth approximately $113,000. New York State Teachers Retirement System boosted its position in shares of Phibro Animal Health by 16.7% during the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after acquiring an additional 775 shares during the last quarter. Amundi increased its position in Phibro Animal Health by 185.5% in the fourth quarter. Amundi now owns 9,855 shares of the company’s stock worth $212,000 after purchasing an additional 6,403 shares during the last quarter. Finally, Zacks Investment Management purchased a new stake in shares of Phibro Animal Health during the 3rd quarter valued at about $274,000. 99.34% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
PAHC has been the topic of several analyst reports. Barclays boosted their target price on Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research report on Monday, February 10th. StockNews.com lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Tuesday, March 25th. Finally, Morgan Stanley raised their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $21.00.
Phibro Animal Health Stock Performance
Shares of PAHC opened at $20.22 on Friday. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. The stock has a 50-day moving average of $22.77 and a two-hundred day moving average of $22.66. The stock has a market cap of $818.97 million, a P/E ratio of 42.13, a P/E/G ratio of 0.45 and a beta of 0.58. Phibro Animal Health Co. has a one year low of $12.30 and a one year high of $26.55.
Phibro Animal Health (NASDAQ:PAHC – Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. As a group, research analysts predict that Phibro Animal Health Co. will post 1.95 EPS for the current year.
Phibro Animal Health Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.37%. The ex-dividend date was Wednesday, March 5th. Phibro Animal Health’s payout ratio is presently 100.00%.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
See Also
- Five stocks we like better than Phibro Animal Health
- Stock Average Calculator
- Charles Schwab Stock: Trading Up in a Down Market
- Business Services Stocks Investing
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- Using the MarketBeat Dividend Yield Calculator
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.